Rhythm Biosciences Ltd. appointed Glenn Gilbert as COO.
Most recently, Gilbert served as head of sales and marketing, with oversight of global product commercialization, at pharmaceutical and device maker Medical Developments International Ltd.
Gilbert has previously held leadership roles at CSL Ltd.'s biotherapeutics arm, now known as Seqirus.
Australia-based Rhythm Biosciences develops and commercializes medical diagnostics technology.
